CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...

The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

The Insight Partners published latest research study on “Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User, and Geography,” the ...

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...

Indonesia is set to host its first-ever plasma fractionation plant in Karawang, West Java, which is poised to become the ...

The global plasma fractionation market can be segmented by product type, application, end-user, and geography. Some of the key players in the global plasma fractionation market include CSL Behring LLC ...

ADMA Biologics receives FDA approval for a process enhancing plasma production yields by 20%, boosting growth and capacity for its products. ADMA Biologics, Inc. has announced the U.S. FDA approval of ...

New York, Sept. 23, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Plasma Fractionation Market by Product, Application, End User ...

The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028. According to the ...

Plasma Fractionation Market size was valued at around USD 33.43 billion in 2023 to reach a value of USD 63.27 billion by 2031, CAGR of 8.3% over (2024–2031 ...